iSOFT Launches Web-Based E-Prescribing Solution for the NHS

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) has launched a new e-prescribing and medication administration (ePMA) solution in the UK and is close to finalising deals with a number of NHS trusts to become early adopters.

The solution is already used at ten hospitals in Australia and across six district health boards in New Zealand for safer and more efficient medicines management. Users report sharp falls in incidents due to drugs being wrongly prescribed or doses being missed. And incidents due to illegible scripts are a thing of the past.

Working with First DataBank, a leading provider of drug databases and active clinical decision support, iSOFT has adapted the solution for the UK market. It offers a drug formulary and decision support rules engine to stop drugs being wrongly prescribed and so shorten hospital stays. It will also streamline processes such as discharge, reduce re-admission rates, and cut costs.

"We have a very strong, if not unique, proposition in combining the scale and capability of iSOFT to deliver a best of breed ePMA solution," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business.

"This is also very timely following the recent publication of the UK government's white paper, Equity and Excellence: Liberating the NHS, which highlights the importance of improving healthcare outcomes and patient safety.

"Last year, the National Patient Safety Agency reported that more than 200 patients every month need further treatment or die because of medication mistakes. Our ePMA solution can help to drastically reduce this statistic."

The solution is specifically designed to allow NHS trusts that have already invested in elements of an electronic patient record to introduce a fully integrated and comprehensive ePMA solution.

Mark Treleaven, Sales and Marketing Director, First DataBank said: "It is clear that iSOFT's new solution has been designed to meet the specialist requirements of prescribing and administering medicines. As such, we are very excited to see our product associated with an initiative that will make full use of the Multilex DDF sophistication."

The first early adopter sites are expected to go-live in 2011. The software will be exhibited at various events throughout the year including E-Health Insider Live in November.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 countries worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI Sharpens Pathologists' Interpret…

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately...

AI Tool Detects Surgical Site Infections…

A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with high accuracy from patient-submitted postoperative wound photos, potentially transforming...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...